Abstract

Aceclofenac 1.5% Pluronic Lecithin Organogel

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2009 - Veterinary Compounding

Page(s): 428

Download in electronic PDF format for $75

Abstract

A formulation for preparing Aceclofenac 1.5% Pluronic Lecithin Organogel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2009 Pg. 428	Aceclofenac 1.5% Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 446	Aceclofenac 1.5% Gel-Cream Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
Jan/Feb 2022 Pg. 65-71	Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Nov/Dec 2010 Pg. 514	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Nov/Dec 2010 Pg. 513	Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 256-261	Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Nov/Dec 2008 Pg. 543	Indomethacin 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2009 Pg. 182-190	Update on Managing Neuropathic Pain Author(s): McNulty Jack P, Muller George
May/Jun 2010 Pg. 204-206	Managing Pain with Transdermal Ketoprofen Author(s): Williams KaCee D
May/Jun 2009 Pg. 244	Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 245	Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 242-246	Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
May/Jun 2014 Pg. 182-188	A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications Author(s): Warner Meredith, Tuder Dmitry
Mar/Apr 2016 Pg. 107-113	Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Author(s): Rabi Joseph
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi